A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis

R Beyaert1, K Heyninck, S Van Huffel

  • 1Unit of Molecular Signal Transduction in Inflammation, Department of Molecular Biology, Ghent University, Ghent, Belgium. rudi@dmb.rug.ac.be

Biochemical Pharmacology
|September 29, 2000
PubMed

Insights

The zinc finger protein A20 inhibits nuclear factor-kappa B (NF-kappa B) activation and apoptosis, crucial for cell survival. A20 and its binding proteins show promise as novel therapeutic agents for diseases linked to NF-kappa B dysregulation.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Immunology

Background:

  • Nuclear factor-kappa B (NF-kappa B) and apoptosis are vital for cellular processes.
  • Dysregulation of NF-kappa B and apoptosis is implicated in diseases like inflammation and cancer.
  • Negative regulatory mechanisms for these pathways are not fully understood.

Purpose of the Study:

  • To review the role of the zinc finger protein A20.
  • To explore A20's function as a dual inhibitor of NF-kappa B activation and apoptosis.
  • To discuss A20's potential as a therapeutic target.

Main Methods:

  • Literature review focusing on A20 and its associated proteins.
  • Analysis of signaling pathways involving NF-kappa B and apoptosis.
  • Examination of A20's inducible expression patterns.

Main Results:

  • A20 acts as a negative feedback regulator in cellular signaling.
  • A20 expression is induced by various stimuli, including cytokines and microbial products.
  • Several A20-binding proteins have been identified, contributing to its regulatory functions.

Conclusions:

  • A20 is a key inhibitor of NF-kappa B signaling and apoptosis.
  • A20-binding proteins are integral to A20's mechanism of action.
  • A20 and its interacting proteins represent potential therapeutic strategies for related diseases.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...